RPRX - Royalty Pharma announces pricing of $1.5B of senior unsecured notes June, 03 2024 05:21 PM Royalty Pharma plc 2024-06-03 17:21:16 ET More on Royalty Pharma Royalty Pharma: Solid Start Of The Year, Buy Confirmed Agios in pact with Royalty Pharma for brain tumor candidate Cytokinetics to get up to $575M in funding from Royalty Pharma Seeking Alpha’s Quant Rating on Royalty Pharma For further details see: Royalty Pharma announces pricing of $1.5B of senior unsecured notes